retatrutide
Retatrutide is a triple-agonist compound currently under clinical investigation. Research has focused on GLP-1, GIP and glucagon pathways and their relationship to appetite regulation, metabolism and body-weight outcomes.
5mg 1.2M IDR | 10mg 2.2M IDR | 20mg 4.0M IDRVIEW RESEARCH →


